All Comments by

  1. Ammar Al-Chalabi on Blood Marker May Predict ALS Progression
  2. Ammar Al-Chalabi on Heritability of Amyotrophic Lateral Sclerosis: Insights From Disparate Numbers.
  3. Rakez Kayed on Two Classes of Aβ Oligomers Act Differently in the Brain
  4. Kiran Bhaskar on To Be Hale and Hearty, Brain Microglia Need a Healthy Gut
  5. Kunie Ando, Charles Duyckaerts and Jean-Pierre Brion on New Role For PICALM: Flushing Aβ From the Brain
  6. Sanjay Pimplikar on Meta-Analyses Deliver Most Definitive Data Yet on Amyloid Prevalence
  7. Luc Dupuis on Dueling Data Variously Say Diabetes Increases, or Decreases, ALS Risk
  8. Hugo Geerts on Shape of a Hug: How the Embrace of a Therapeutic Aβ Antibody Really Matters
  9. Ronald DeMattos, Robert Dean and Eric Siemers on Shape of a Hug: How the Embrace of a Therapeutic Aβ Antibody Really Matters
  10. Taisuke Tomita on New Role For PICALM: Flushing Aβ From the Brain
  11. Amalia Cecilia Bruni, Maria Elena Conidi and Livia Bernardi on APP A713T
  12. Michael Costigan on Mouse Axons CAST Off Inhibitors for Stunning Regeneration
  13. Hugo Geerts on Computational Modeling—Will it Rescue AD Clinical Trials?
  14. Pieter Jelle Visser on Could New Fluid Biomarkers Refine Alzheimer’s Diagnosis?
  15. Steve Barger on d-serine levels in Alzheimer's disease: implications for novel biomarker development.